Miniaturized noninvasive glucose sensor and continuous glucose monitoring system
The disclosed techniques involve a light emitter configured to emit light toward the skin of a person, a light emitter controller configured to control the light emitter to emit the light in pulses having a pulse duration and at a pulse repetition frequency, a resonance chamber positioned to receive acoustic waves generated in the person in response to the light emitted by the light emitter, a sensor configured to sense acoustic waves in the resonance chamber, and a signal processor configured to estimate a glucose concentration level in the person based on the acoustic waves sensed by the sensor. The resonance chamber is sized to form a standing wave that has an acoustic wavelength of interest when glucose analytes are present in the region of the skin of the person. The pulse duration and the pulse repetition frequency of the emitted light are set at values that support the standing wave having the acoustic wavelength of interest.
1. A glucose monitor comprising:
a light emitter configured to emit light toward skin of a person;
a light emitter controller configured to control the light emitter to emit the light in pulses having a pulse duration and at a pulse repetition frequency;
a resonance chamber positioned to receive acoustic waves generated in the person in response to the light emitted by the light emitter, the resonance chamber sized to form a standing wave having an acoustic wavelength of interest, when glucose analytes are present in a region of the skin of the person;
a sensor facing the skin of the person and configured to sense acoustic waves in the resonance chamber, wherein the sensor and the light emitter are positioned side-by-side and face a same direction towards the skin of the person; and
a signal processor configured to estimate a glucose concentration level in the person based on the acoustic waves sensed by the sensor,
wherein the pulse duration and the pulse repetition frequency of the emitted light are set at values that support the standing wave having the acoustic wavelength of interest.
2. The glucose monitor of claim 1 , wherein the light emitter is configured to emit light having a wavelength in a mid-infrared region.
3. The glucose monitor of claim 1 , wherein the sensor is positioned proximate to an anti-node of the standing wave to be formed in the resonance chamber.
4. The glucose monitor of claim 1 , wherein the signal processor is configured to determine whether the estimated glucose concentration level falls within one of two or more pre-determined ranges.
5. The glucose monitor of claim 4 , further comprising a transmitter configured to transmit a signal when the estimated glucose concentration level falls within a particular range of the two or more pre-determined ranges.
6. The glucose monitor of claim 1 , wherein the light emitter is a light emitting diode that emits diffuse light.
7. The glucose monitor of claim 1 , further comprising:
a case enclosing the light emitter, the light emitter controller, the resonance chamber, the sensor, and the signal processor,
wherein the case has a length below 20 mm and a width below 20 mm.
8. The glucose monitor of claim 7 , wherein the case includes a case cover having an electronic transmitter incorporated therein, the case cover configured to be positioned on the skin of the person.
9. The glucose monitor of claim 1 , wherein the sensor includes a microphone or a piezoelectric transducer.
10. The glucose monitor of claim 1 , wherein the light emitter and the sensor are positioned inside the resonance chamber.
11. A method for estimating a glucose concentration level in a person, the method comprising:
emitting light from a light emitter toward skin of the person;
controlling, by a light emitter controller, the light emitter to emit the light in pulses having a pulse duration and at a pulse repetition frequency;
receiving, in a resonance chamber, acoustic waves generated in the person in response to the light emitted by the light emitter, the resonance chamber sized to form a standing wave having an acoustic wavelength of interest, when glucose analytes are in a region of the skin of the person;
sensing, by a sensor positioned side-by-side with the light emitter and facing a same direction towards the skin of the person with the light emitter, acoustic waves in the resonance chamber; and
estimating, by a signal processor, the glucose concentration level in the person based on the acoustic waves sensed by the sensor,
wherein the pulse duration and the pulse repetition frequency of the emitted light are set at values that support the standing wave having the acoustic wavelength of interest.
12. The method of claim 11 , wherein emitting the light from the light emitter comprises emitting light having a wavelength in a mid-infrared region.
13. The method of claim 11 , wherein the sensor is positioned proximate to an anti-node of the standing wave to be formed in the resonance chamber.
14. The method of claim 11 , further comprising determining, by the signal processor, whether the estimated glucose concentration level falls within one of two or more pre-determined ranges.
15. The method of claim 14 , further comprising transmitting, by a transmitter, a signal when the estimated glucose concentration level falls within a particular range of the two or more pre-determined ranges.
16. The method of claim 11 , wherein the light emitter is a light emitting diode that emits diffuse light.
17. The method of claim 11 , wherein the light emitter, the light emitter controller, the resonance chamber, the sensor, and the signal processor are enclosed in a case, and wherein the case has a length below 20 mm and a width below 20 mm.
18. The method of claim 17 , wherein the case includes a case cover having an electronic transmitter incorporated therein.
19. The method of claim 11 , wherein the sensor includes a microphone or a transducer.